Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Legal Issues Author: The Federal Trade Commission Last Updated: Jan 25, 2012 - 12:23:16 PM



FTC Seeks Public Comment on Healthcare Technology's Application to Sell SDI Health's Audit Businesses

By The Federal Trade Commission
Jan 25, 2012 - 12:20:42 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - The Federal Trade Commission seeks public comment on an application by Healthcare Technology Holdings, Inc., which is requesting approval to sell two audit businesses of SDI Health LLC to inVentiv Health, Inc. A divestiture is required by the final FTC settlement order allowing Healthcare Technology's subsidiary IMS Health Inc. to acquire SDI Health.

According to the application, the sale of SDI Health's audit businesses would satisfy the terms of the FTC's final order, which settled FTC charges that the deal would have been anticompetitive and in violation of the FTC and Clayton Acts. The audit businesses include SDI's promotional audit business and medical audit business.

The Commission will decide whether to approve the sale after the expiration of the public comment period. Public comments on the application may be submitted until February 27, 2012. Written comments should be sent to: FTC Office of the Secretary, 600 Pennsylvania Ave., N.W., Washington, DC 20580. Comments also can be filed electronically. Copies of the application also can be found on the FTC's website and as a link to this press release. (FTC File No. 111-0097, Docket No. C-4340; the staff contact is Roberta S. Baruch, Bureau of Competition, 202-326-2861; see press release dated October 28, 2011.)

The FTC's Bureau of Competition works with the Bureau of Economics to investigate alleged anticompetitive business practices and, when appropriate, recommends that the Commission take law enforcement action. To inform the Bureau about particular business practices, call 202-326-3300, send an e-mail to antitrust@ftc.gov, or write to the Office of Policy and Coordination, Bureau of Competition, Federal Trade Commission, 601 New Jersey Ave., Room 7117, Washington, DC 20580. To learn more about the Bureau of Competition, read Competition Counts. Like the FTC on Facebook and follow us on Twitter.

###

For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: tvmike13@HealthNewsDigest.com or 877-634-9180
HealthNewsDigest.com is syndicated worldwide and has over 7,000 journalists as subscribers.
www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

Legal Issues
Latest Headlines


+ FTC Approves Final Settlement with CVS Caremark
+ $78.5 Million Jury Verdict In Philadelphia Birth Injury Case
+ American Academy of Implant Dentistry Sues Texas Dental Board
+ FTC Closes Eight-Month Investigation of Express Scripts, Inc.'s Proposed Acquisition of Pharmacy Benefits Manager Medco Health Solutions, Inc.
+ FDA Acts To Stop Tobacco Industry Deception About Health Risks of Products
+ FTC Testifies on Proposed Antitrust Exemption for Community Pharmacies
+ Citing Likely Anticompetitive Effects, FTC Requires ProMedica Health System to Divest St. Luke's Hospital in Toledo, Ohio
+ FTC Action Puts Robocallers Out of the Telemarketing Business
+ Supreme Court's Affordable Care Act Decision Will Have Massive, Immediate Impact
+ FTC Legal Action Halts Alleged Mortgage Relief Scammers Who Lured Homeowners with Bogus Claims



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions